DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Share Price

Certificat

DE000ME79EF7

Real-time Bid/Ask 16:21:29 03/07/2024 BST
81.06 EUR / 81.1 EUR -0.80% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.16%
1 month+1.87%
Date Price Change
03/07/24 81.38 -0.43%
02/07/24 81.73 -0.09%
01/07/24 81.8 -0.07%
28/06/24 81.86 0.00%
27/06/24 81.86 -0.22%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 10:52 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN ME79EF
ISINDE000ME79EF7
Date issued 22/01/2024
Cap 90 $
Last trading day 20/12/2024
Maturity 20/12/2024 (170 Days)
Parity 1 : 1
Emission price 76.68
Emission volume N/A
Payment day 31/12/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 36.59 %
Sideways yield 2.778 %
Sideways yield pa 5.965 %
Outperformance point 141.9 $
Break even 87.57 €
Highest since issue 82.04
Lowest since issue 74.39
Spread 0.02
Spread %0.02%
Distance Cap 47.16 $
Distance Cap %+34.39%
Max. earning 2.252
Max. earning % 2.778 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus